Co-located quantitative trait loci mediate resistance to Agrobacterium tumefaciens, Phytophthora cinnamomi, and P. pini in Juglans microcarpa × J. regia hybrids

Co-located quantitative trait loci mediate resistance to Agrobacterium tumefaciens, Phytophthora cinnamomi, and P. pini in Juglans microcarpa × J. regia hybrids

Soil-borne plant pathogens characterize a critical risk that undermines industrial walnut (Juglans regia) manufacturing worldwide. Crown gall, attributable to Agrobacterium tumefaciens, and Phytophthora root and crown rots, attributable to varied Phytophthora spp., are among the many most devastating walnut soil-borne ailments.
A acknowledged technique to fight soil-borne ailments is adoption of resistant rootstocks. Right here, resistance to A. tumefaciens, P. cinnamomi, and P. pini is mapped within the genome of Juglans microcarpa, a North American wild relative of cultivated walnut. Half-sib J. microcarpa mom bushes DJUG 31.01 and DJUG 31.09 had been crossed with J. regia cv. Serr, producing 353 and 400 hybrids, respectively.
Clonally propagated hybrids had been genotyped by sequencing to assemble genetic maps for the 2 populations and challenged with the three pathogens. Resistance to every of the three pathogens was mapped as a serious QTL on the lengthy arm of J. microcarpa chromosome 4D and was related to the identical haplotype, designated as haplotype b, elevating the likelihood that the 2 mom bushes had been heterozygous for a single Mendelian gene conferring resistance to all three pathogens.
The deployment of this haplotype in rootstock breeding will facilitate breeding of a walnut rootstock immune to each crown gall and Phytophthora root and crown rots.

A number of Viral Infections Detected in Phytophthora condilina by Complete and Small RNA Sequencing

Marine oomycetes have lately been proven to be concurrently contaminated by (-)ssRNA viruses of the order Bunyavirales. On this work, even greater virus variability was present in a single isolate of Phytophthora condilina, a lately described member of Phytophthora phylogenetic Clade 6a, which was remoted from brackish estuarine waters in southern Portugal.
Utilizing complete and small RNA-seq the total RdRp of 13 totally different potential novel bunya-like viruses and two full toti-like viruses had been detected. All these viruses had been efficiently confirmed by reverse transcription polymerase chain response (RT-PCR) utilizing complete RNA as template, however complementarily one of many toti-like and 5 of the bunya-like viruses had been confirmed when dsRNA was purified for RT-PCR. In our examine, complete RNA-seq was by much more environment friendly for de novo assembling of the virus sequencing however small RNA-seq confirmed greater learn numbers for many viruses.
Co-located quantitative trait loci mediate resistance to Agrobacterium tumefaciens, Phytophthora cinnamomi, and P. pini in Juglans microcarpa × J. regia hybrids
Two fundamental populations of small RNAs (21 nts and 25 nts-long) had been recognized, which had been in accordance with different Phytophthora species. To the very best of our information, that is the primary examine utilizing small RNA sequencing to determine viruses in Phytophthora spp.

Stepwise accumulation of mutations in CesA3 in Phytophthora sojae leads to rising resistance to CAA fungicides

Flumorph is a carboxylic acid amide (CAA) fungicide with excessive exercise towards oomycetes. Nonetheless, evolution to CAAs from low resistance to excessive resistance has by no means been reported. This examine investigated the premise of resistance evolution of flumorph in Phytophthora sojae.
Complete of 120 P. sojae isolates had been collected and their sensitivity to flumorph was evaluated. Though no spontaneous resistance was discovered among the many area isolates, adaptation on flumorph-amended media resulted within the collection of 5 steady mutant varieties exhibiting various levels of resistance to CAAs.
Kind I, which exhibited the bottom resistance stage, was obtained when the wild-type isolate was uncovered to a low focus of flumorph, however no resistant mutants had been obtained by direct publicity to greater concentrations. Nonetheless, the extra resistant varieties (Kind II, III, IV and V) had been obtained when Kind I had been uncovered to greater concentrations of flumorph.
Comparable outcomes had been obtained when your entire screening course of was repeated, which implied that evolution of resistance to flumorph in P. sojae could possibly be a two-step course of, the place excessive resistance phenotypes may develop regularly from low resistance ones.
Additional investigation into molecular mechanism strongly confirmed that evolution of isolates extremely immune to flumorph happens in a stepwise course of with Kind I as middleman, by means of accumulation of mutations of their goal protein of CAAs (CesA3). Collectively, our findings point out that software of low charges of flumorph in area may lead to collection of low resistance Kind I isolates, however that elevating dosage to keep up comparable ranges of management may elicit speedy evolution of extra resistant Kind II, III, IV and V isolates with stepwise accumulation of mutations in CesA3, which might render flumorph ineffective as a management technique.

GCN5 highly active Recombinant Protein

90-345 2 ug
EUR 500.1
Description: GCN5 functions as a histone acetyltransferase (HAT) to promote transcriptional activation. Acetylation of histones gives a specific tag for epigenetic transcription activation. It has significant histone acetyltransferase activity with core histones, but not with nucleosome core particles. In case of HIV-1 infection, it is recruited by the viral protein Tat. It regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. GCN5 is a component of the Ada Two-A containing (ATAC) complex, a complex with histone acetyltransferase activity on histones H3 and H4.

PARG highly active Recombinant Protein

90-350 2 ug
EUR 500.1
Description: Poly(ADP-ribose) synthesized after DNA damage is only present transiently and is rapidly degraded by poly(ADP-ribose) glycohydrolase. PARG hydrolyzes poly(ADP-ribose) at glycosidic (1''-2') linkage of ribose-ribose bond to produce free ADP-ribose.

TIP60 highly active Recombinant Protein

90-347 2 ug
EUR 500.1
Description: TIP60 is the catalytic subunit of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of selected genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex is required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. TIP60 directly acetylates and activates ataxia-telangiectasia mutated (ATM). In case of HIV-1 infection, interaction with the viral Tat protein leads to KAT5 polyubiquitination and targets it to degradation.

NMNAT1 highly active Recombinant Protein

90-354 10 ug
EUR 437.1
Description: Nuclear NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. It can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Interacts with PARP-1/ARTD1. Protects against axonal degeneration following mechanical or toxic insults. Widely expressed.

NMNAT1 highly active Recombinant Protein

90-355 50 ug
EUR 619.8
Description: Nuclear NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. It can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Interacts with PARP-1/ARTD1. Protects against axonal degeneration following mechanical or toxic insults. Widely expressed.

NMNAT3 highly active Recombinant Protein

90-356 10 ug
EUR 468.6
Description: Mitochondrial NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Can use tiazofurin monophosphate as substrate. Can also use GTP and ITP as nucleotide donors. Also catalyzes the reverse reaction, i. e. the pyrophosphorolytic cleavage of NAD+. For the pyrophosphorolytic activity, mitochondrial NMNAT isoform can use NAD(+), NADH, NAAD, nicotinic acid adenine dinucleotide phosphate (NHD), nicotinamide guanine dinucleotide (NGD) as substrates. Fails to cleave phosphorylated dinucleotides NADP+, NADPH and NAADP+. Protects against axonal degeneration following injury.

NMNAT3 highly active Recombinant Protein

90-357 50 ug
EUR 852.9
Description: Mitochondrial NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Can use tiazofurin monophosphate as substrate. Can also use GTP and ITP as nucleotide donors. Also catalyzes the reverse reaction, i. e. the pyrophosphorolytic cleavage of NAD+. For the pyrophosphorolytic activity, mitochondrial NMNAT isoform can use NAD(+), NADH, NAAD, nicotinic acid adenine dinucleotide phosphate (NHD), nicotinamide guanine dinucleotide (NGD) as substrates. Fails to cleave phosphorylated dinucleotides NADP+, NADPH and NAADP+. Protects against axonal degeneration following injury.

NAD Kinase highly active Recombinant Protein

90-353 50 ug
EUR 651.3
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis.

NF-kB p65 highly active Recombinant Protein

90-348 2 ug
EUR 600.9
Description: NF-kappaB is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappaB is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric p65-p50 complex is the most abundant complex. The dimers bind at kappaB sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappaB sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappaB complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappaB inhibitor (I-kappaB) family. In a conventional activation pathway, I-kappaB is phosphorylated by I-kappaB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappaB complex which translocates to the nucleus. NF-kappaB heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappaB p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappaB complex.

NF-kB p50 highly active Recombinant Protein

90-349 2 ug
EUR 632.4
Description: NF-kappaB is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappaB is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric p65-p50 complex is the most abundant complex. The dimers bind at kappaB sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappaB sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappaB complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappaB inhibitor (I-kappaB) family. In a conventional activation pathway, I-kappaB is phosphorylated by I-kappaB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappaB complex which translocates to the nucleus. NF-kappaB heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappaB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3.

Human PARG highly active Recombinant Protein His Tag

IHUPARGHARHIS2UG each
EUR 568
Description: Human PARG highly active Recombinant Protein His Tag

Human GCN5 highly active Recombinant Protein His Tag

IHUGCN5HARHIS2UG each
EUR 568
Description: Human GCN5 highly active Recombinant Protein His Tag

Human TIP60 highly active Recombinant Protein His Tag

IHUTIP60HARHIS2UG each
EUR 568
Description: Human TIP60 highly active Recombinant Protein His Tag

CREB-binding Protein highly active Recombinant Protein

90-344 2 ug
EUR 500.1
Description: CREB-binding protein acetylates histones, giving a specific tag for transcriptional activation. It also acetylates non-histone proteins, like NCOA3 and FOXO1. It binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1 in the presence of EP300.

Human NMNAT1 highly active Recombinant Protein His Tag

IHUNMNAT1HARHIS10UG each
EUR 479
Description: Human NMNAT1 highly active Recombinant Protein His Tag

Human NMNAT1 highly active Recombinant Protein His Tag

IHUNMNAT1HARHIS50UG each
EUR 721
Description: Human NMNAT1 highly active Recombinant Protein His Tag

Human NMNAT3 highly active Recombinant Protein His Tag

IHUNMNAT3HARHIS10UG each
EUR 519
Description: Human NMNAT3 highly active Recombinant Protein His Tag

Human NMNAT3 highly active Recombinant Protein His Tag

IHUNMNAT3HARHIS50UG each
EUR 1029
Description: Human NMNAT3 highly active Recombinant Protein His Tag

BAFF, Soluble 60-mer highly active Recombinant Protein

90-294 10 ug
EUR 537.9
Description: BAFF is mainly produced by innate immune cells such as neutrophils, monocytes, macrophages, dendritic cells, follicular dendritic cells. T cells, activated B cells, some malignant B cells and also non-lymphoid cells like astrocytes, synoviocytes and epithelial cells can also produce BAFF. BAFF binds three distinct receptors (BAFF-R, TACI and BCMA) expressed predominantly on B cells, although activated T cells also express BAFF-R. BAFF is a master regulator of peripheral B cell survival, and together with IL-6, promotes Ig class-switching and plasma cell differentiation. Besides its major role in B cell biology, BAFF co-stimulates activated T cells. Deregulated expression of BAFF leads to autoimmune disorders in mice. In humans, elevated levels of soluble BAFF have been detected in the serum of patients with various autoimmune diseases such as Sjoegren syndrome, Rheumatoid arthritis (RA), Multiple sclerosis (MS) and Systemic Lupus Erythematosus (SLE). BAFF has also increased levels in some lymphoid cancers. Processed human BAFF can either remain as a trimer, which is usual for TNF family ligands or assemble into 60-mer composed of 20 trimers. Mouse BAFF 60-mer has been identified in the serum of BAFF transgenic mice. Oligomerization of BAFF 3-mer into 60-mer in human BAFF is prevented by mutation of His218, a residue critical for 3-mer-to-3-mer interactions, but not for receptor binding. Despite the predominant functional role of processed BAFF in vivo, membrane-bound BAFF might also play a role. Indeed, soluble BAFF (3-mer) can trigger BAFF-R but not TACI or BCMA, whereas oligomeric forms of BAFF (BAFF 60-mer), which mimic membrane-bound BAFF, activate all BAFF receptors.

Human NAD Kinase highly active Recombinant Protein His Tag

IHUNADKHARHIS50UG each
EUR 762
Description: Human NAD Kinase highly active Recombinant Protein His Tag

NAD Kinase catalytic domain highly active Recombinant Protein

90-352 50 ug
EUR 752.1
Description: NAD kinase catalyzes the transfer of a phosphate group from ATP to NAD+ to generate NADP+, which in its reduced form acts as an electron donor for biosynthetic reactions. NADP+ is an essential coenzyme in metabolism and provides reducing power to biosynthetic processes such as fatty acid biosynthesis.

Human NF-kB p50 highly active Recombinant Protein His Tag

IHUNFKBP50HARHIS2UG each
EUR 738
Description: Human NF-kB p50 highly active Recombinant Protein His Tag

Human NF-kB p65 highly active Recombinant Protein His Tag

IHUNFKBP65HARHIS2UG each
EUR 697
Description: Human NF-kB p65 highly active Recombinant Protein His Tag

FGF acidic Recombinant Protein

40-493-001mg 0.01 mg
EUR 311.1
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant murine FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues.

FGF acidic Recombinant Protein

40-493-005mg 0.05 mg
EUR 437.1
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant murine FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues.

Mouse CREB-binding Protein highly active Recombinant Protein His Tag

IMSCREBBDPROHARHIS2UG each
EUR 568
Description: Mouse CREB-binding Protein highly active Recombinant Protein His Tag

Rat FGF acidic Recombinant Protein

R20-018 50 µg
EUR 196.35
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development, postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant rat FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues.

Rat FGF acidic Recombinant Protein

R20-018S 10 µg
EUR 92.4
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development, postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant rat FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues.

Human FGF acidic Recombinant Protein

100-016 50 µg
EUR 196.35
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant human FGF-acidic is a 15.8 kDa protein consisting of 140 amino acid residues.

Human FGF acidic Recombinant Protein

100-016S 10 µg
EUR 92.4
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant human FGF-acidic is a 15.8 kDa protein consisting of 140 amino acid residues.

Mouse FGF acidic Recombinant Protein

M10-045 50 µg
EUR 196.35
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant mouse FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues.

Mouse FGF acidic Recombinant Protein

M10-045S 10 µg
EUR 92.4
Description: FGF-acidic is one of 23 known members of the FGF family. Proteins of this family play a central role during prenatal development and postnatal growth and regeneration of a variety of tissues, by promoting cellular proliferation and differentiation. FGF-acidic is a non-glycosylated heparin binding growth factor that is expressed in the brain, kidney, retina, smooth muscle cells, bone matrix, osteoblasts, astrocytes and endothelial cells. FGF-acidic has the ability to signal through all the FGF receptors. Recombinant mouse FGF-acidic is a 15.9 kDa protein consisting of 141 amino acid residues.

Human NAD Kinase catalytic domain highly active Recombinant Protein His Tag

IHUNADKCTLYDHARHIS50UG each
EUR 899
Description: Human NAD Kinase catalytic domain highly active Recombinant Protein His Tag

Genorise® recombinant monkey FGF Acidic

GR175084 5 mg
EUR 285

Human / Mouse BAFF, Soluble 60-mer highly active Recombinant Protein His Tag Lyophilized

IHUMSBAFFS60MERHARHISLY10UG each
EUR 616
Description: Human / Mouse BAFF, Soluble 60-mer highly active Recombinant Protein His Tag Lyophilized

Genorise® Recombinant Guinea Pig FGF Acidic

GR177027 5 mg
EUR 285

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41608-100ug 100ug
EUR 431.2

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41608-1mg 1mg
EUR 1911

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41608-50ug 50ug
EUR 346.5

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41609-100ug 100ug
EUR 431.2

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41609-1mg 1mg
EUR 1911

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41609-50ug 50ug
EUR 346.5

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41610-100ug 100ug
EUR 419.1

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41610-1mg 1mg
EUR 1856.4

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41610-50ug 50ug
EUR 336.6

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41611-100ug 100ug
EUR 419.1

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41611-1mg 1mg
EUR 1856.4

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41611-50ug 50ug
EUR 336.6

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41612-100ug 100ug
EUR 419.1

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41612-1mg 1mg
EUR 1856.4

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU41612-50ug 50ug
EUR 336.6

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU50610-100ug 100ug
EUR 431.2

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU50610-1mg 1mg
EUR 1911

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU50610-50ug 50ug
EUR 346.5

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU55169-100ug 100ug
EUR 431.2

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU55169-1mg 1mg
EUR 1911

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU55169-50ug 50ug
EUR 346.5

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU55170-100ug 100ug
EUR 431.2

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU55170-1mg 1mg
EUR 1911

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPU55170-50ug 50ug
EUR 346.5

Mouse FGF acidic Recombinant Protein Lyophilized

IMSFGFARLY10UG each
EUR 341
Description: Mouse FGF acidic Recombinant Protein Lyophilized

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Hu01 10ug
EUR 140

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Hu02 10ug
EUR 140

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Hu02
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Hu04 10ug
EUR 142

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Hu05 10ug
EUR 143

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Mu01 10ug
EUR 136

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Mu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Mu02 10ug
EUR 136

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Mu02
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Mu03 10ug
EUR 136

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Mu03
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Mu04 10ug
EUR 140

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Mu04
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Ra01 10ug
EUR 140

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Ra01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Glial Fibrillary Acidic Protein (GFAP)

RPA068Ra02 10ug
EUR 140

Recombinant Glial Fibrillary Acidic Protein (GFAP)

4-RPA068Ra02
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Glial Fibrillary Acidic Protein expressed in: E.coli

Recombinant Mouse FGF1/FGFa/FGF acidic Protein

E40KMP1629 20ug
EUR 495

Recombinant Human Acidic mammalian chitinase (CHIA)

CSB-EP874858HU 4640 mg Ask for price

Recombinant Human Acidic mammalian chitinase(CHIA)

AP76911 1mg
EUR 1978

Recombinant Human Acidic Fibroblast Growth Factor

45101 20ug
EUR 341

Recombinant Cryptochrome 1 (CRY1)

RPU52142-100ug 100ug
EUR 517

Recombinant Cryptochrome 1 (CRY1)

RPU52142-1mg 1mg
EUR 2293.2

Recombinant Cryptochrome 1 (CRY1)

RPU52142-50ug 50ug
EUR 415.8

Recombinant Cryptochrome 1 (CRY1)

RPC407Hu01 10ug
EUR 168

Recombinant Cryptochrome 1 (CRY1)

4-RPC407Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Cryptochrome 1 expressed in: E.coli

Recombinant Murine Acidic Fibroblast Growth Factor

AP60184 100ug
EUR 449

Recombinant rat FGF Acidic/Fgf1 Protein, No Tag

E40PO135 20ug
EUR 495

Recombinant FGF acidic Protein (Phe 16-Asp 155)

VAng-1552Lsx-1mg 1 mg
EUR 2370
Description: Human FGF acidic is expressed in HEK 293 cells. (Uniprot ID: NP_000791)

Recombinant FGF acidic Protein (Phe 16-Asp 155)

VAng-1552Lsx-200g 200 µg
EUR 654
Description: Human FGF acidic is expressed in HEK 293 cells. (Uniprot ID: NP_000791)

Genorise® recombinant human FGF acidic protein

GR119085 5 µg
EUR 285

Genorise® recombinant Sheep FGF Acidic protein

GR123010 5 µg
EUR 285

Genorise® recombinant Mouse FGF acidic protein

GR124085 5 µg
EUR 285

Genorise® recombinant Bovine FGF Acidic protein

GR120059 5 µg
EUR 285

Genorise® recombinant Canine FGF Acidic protein

GR122083 5 µg
EUR 285

Genorise® Recombinant Equine FGF Acidic protein

GR104326 5 µg
EUR 285

Recombinant human Acidic repeat-containing protein

P2170 100ug Ask for price
Description: Recombinant protein for human Acidic repeat-containing protein

Recombinant Human FGF Acidic/FGF1 Protein, No Tag

E40KMH1083 20ug
EUR 495

Recombinant Human FGF Acidic/FGF1 Protein, No Tag

E40KMH1084 20ug
EUR 495

Genorise® recombinant porcine FGF acidic protein

GR189016 5 µg
EUR 285

Proline-Rich Acidic Protein 1 Human Recombinant

rAP-3996 Inquiry Ask for price

Recombinant human FGF acidic/FGF1 Protein, His Tag

E40KMP1355 20ug
EUR 495

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41430-100ug 100ug
EUR 537.9

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41430-1mg 1mg
EUR 2380.3

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41430-50ug 50ug
EUR 431.2

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41431-100ug 100ug
EUR 599.5

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41431-1mg 1mg
EUR 2653.3

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41431-50ug 50ug
EUR 480.7

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41432-100ug 100ug
EUR 628.1

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41432-1mg 1mg
EUR 2784.6

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41432-50ug 50ug
EUR 504.9

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41433-100ug 100ug
EUR 578.6

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41433-1mg 1mg
EUR 2566.2

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU41433-50ug 50ug
EUR 465.3

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU54232-100ug 100ug
EUR 589.6

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU54232-1mg 1mg
EUR 2610.4

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU54232-50ug 50ug
EUR 473

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU58394-100ug 100ug
EUR 551.1

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU58394-1mg 1mg
EUR 2558.4

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU58394-50ug 50ug
EUR 428.5

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU56417-100ug 100ug
EUR 360.4

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU56417-1mg 1mg
EUR 1672.4

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU56417-50ug 50ug
EUR 257.3

Recombinant Fibroblast Growth Factor 1, Acidic (FGF1)

RPU56418-100ug 100ug
EUR 360.4
Precautionary resistance administration technique needs to be carried out. The phenomenon described within the examine may have broader organic significance.